Results 61 to 70 of about 6,501 (209)

Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022

open access: yesThe Journal of Dermatology, Volume 53, Issue 5, Page e257-e356, May 2026.
ABSTRACT The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes.
Yoshiaki Kinoshita   +116 more
wiley   +2 more sources

Cerebral cavernous malformations associated to meningioma: High penetrance in a novel family mutated in the PDCD10 gene [PDF]

open access: yes, 2015
Multiple familial meningiomas occur in rare genetic syndromes, particularly neurofibromatosis type 2. The association of meningiomas and cerebral cavernous malformations (CCMs) has been reported in few patients in the medical literature.
Al-Shahi Salman R   +14 more
core   +1 more source

Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Vascular malformations in the central nervous system are difficult to monitor and treat due to their inaccessible location. Angiogenic and inflammatory proteins are secreted into the bloodstream and may serve as useful biomarkers for ...
Sarah E. Wetzel-Strong   +10 more
doaj   +1 more source

Angioneogenese in cerebralen Arteriovernösen Malformationen [PDF]

open access: yes, 2004
Arteriovenöse Malformationen werden in der Literatur meistens als angeborene und statische Gefäßmissbildungen beschrieben. Neuere Arbeiten und Erkenntnisse legen jedoch eine dynamische Biologie dieser Malformationen nahe.
Battenberg, Elmar   +1 more
core   +1 more source

Sensitivity of patients with familial cerebral cavernous malformations to therapeutic radiation [PDF]

open access: yesJournal of Medical Imaging and Radiation Oncology, 2015
SummaryFamilial cerebral cavernous malformations are autosomal dominant conditions that can result in significant morbidity. A two‐hit mechanism is accepted as likely responsible for formation of these malformations. We present two patients with this disease who received therapeutic radiation and developed very high numbers of malformations within the ...
Michael, Golden   +5 more
openaire   +2 more sources

Upregulation of transmembrane endothelial junction proteins in human cerebral cavernous malformations [PDF]

open access: yes, 2010
OBJECT: Cerebral cavernous malformations (CCMs) are among the most prevalent cerebrovascular malformations, and endothelial cells seem to play a major role in the disease.
Chappell PM   +8 more
core   +1 more source

Medication intake and hemorrhage risk in patients with Familial Cerebral Cavernous Malformations

open access: yesBrain and Spine, 2022
OBJECTIVE The objective of this study was to analyze the impact of medication intake on hemorrhage risk in patients with familial cerebral cavernous malformation (FCCM). METHODS The authors’ institutional database was screened for patients with FCCM who had been admitted to their department between 2003 and 2020.
Santos, Alejandro N.   +14 more
openaire   +4 more sources

A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation

open access: yesFrontiers in Neurology, 2018
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by the presence of renal cysts and specific extrarenal abnormalities.
Christian Thomas   +7 more
doaj   +1 more source

Familial cerebral cavernous malformation

open access: yesFolia Neuropathologica, 2012
Cavernous malformations (CMs) occur in approximately 0.5% of the general population and represent 5-10% of the central nervous system vascular malformations. The majority of CMs appear sporadically but genetically determined familial forms account for 10% to 15% of all cases.
Matyja, Ewa   +2 more
openaire   +3 more sources

Modeling the lung‒brain axis in critical illness: Multifactorial crosstalk through organoids and organ‐on‐a‐chip system

open access: yesVIEW, EarlyView.
Patients in intensive care units often experience lung injuries, complicated by brain problems. Advanced laboratory tools, organoids, and organs‐on‐chips facilitated the study of multiorgan interactions, help us understand the communication between the lungs and brain.
Wanyi Zhang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy